Skip to main content

Find Clinical Trials

Home
Conditions
Prevention of the Meningococcal Disease

Clinical trial condition

Prevention of the Meningococcal Disease

Explore clinical trials studying Prevention of the Meningococcal Disease. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Prevention of the Meningococcal Disease trial results

Completed

A Phase 3b, Single-Center, Open-label Study to Assess the Immunogenicity and Safety of Novartis Meningococcal B Recombinant Vaccine When Administered at a 0, 2-Month Schedule in Healthy At-Risk Adults Aged 18 to 65 Years Inclusive.

NCT01911221

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: Novartis site Marburg, Germany

View Trial Details